• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Champions Oncology, Inc. - Common Stock (NQ:CSBR)

5.150 +0.340 (+7.07%)
Delayed Quote Updated: 9:38 AM EDT, Oct 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,538
Open 5.150
Bid (Size) 4.840 (100)
Ask (Size) 5.090 (100)
Prev. Close 4.810
Today's Range 5.150 - 5.150
52wk Range 4.590 - 8.310
Shares Outstanding 13,415,066
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Champions Oncology (CSBR) Q1 2027 Earnings Call Transcript ↗
September 11, 2026
Data licensing revenue surged past full-year fiscal 2026 totals in single quarter. 
Via The Motley Fool
Topics Earnings
News headline image
Champions Oncology Q1 Earnings Call Highlights ↗
September 10, 2026
Champions Oncology (NASDAQ:CSBR) reported first-quarter fiscal 2027 revenue growth, improved margins and its fifth consecutive quarter of positive adjusted EBITDA, as both its translational oncology... 
Via MarketBeat
Topics Earnings

Performance

52-Week Range 38.0% below 52-week high
5.150
4.5952W Low 8.3152W High
1 Week
4.631W Low 4.871W High

Champions Oncology, Inc. - Common Stock (CSBR) traded between $4.59 and $8.31 over the past 52 weeks and last traded at $5.15, 38.0% below its 52-week high. Over the past week it ranged between $4.63 and $4.87.

Past 12 Months
+7.1%
-2.1%
-15.6%
-11.2%
-22.7%
-21.1%
1W +$0.34
1M -$0.11
3M -$0.95
6M -$0.65
YTD -$1.51
1Y -$1.38

CSBR was -21.1% over the past year, -11.2% over six months, -22.7% year to date, +7.1% in the last week.

12 Months vs Market
CSBR
-21.1%
DIA
+12.1%
SPY
+14.6%
QQQ
+17.9%
IWM
+11.4%

Over the past 12 months CSBR returned -21.1% versus DIA (Dow) +12.1%, SPY (S&P 500) +14.6%, QQQ (Nasdaq 100) +17.9% and IWM (Russell 2000) +11.4%.

Volume & Liquidity 0.14× 3-mo avg
Today 1,538 3-mo avg 10.9K
1W
6.3K
1M
9.1K
3M
10.9K
6M
9.9K
YTD
8.9K
1Y
10.3K

CSBR most recently traded 1,538 shares against a 3-month average daily volume of 10.9K.

More News

Read More
Champions Oncology (NASDAQ:CSBR) Shares Jump as Q1 Margins Expand and Adjusted EBITDA Turns Higher ↗
September 10, 2026
Via Chartmill
News headline image
Champions Oncology Reports Revenue of $15.2 Million
September 10, 2026
From Champions Oncology, Inc.
Via ACCESS Newswire
Champions Oncology (NASDAQ:CSBR) Surges on Earnings Beat and Margin Expansion, Highlighting Quality Growth Stock ↗
July 27, 2026
Via Chartmill
Topics Earnings
Champions Oncology Inc. (NASDAQ:CSBR) Shares Surge on Record Study Revenue Despite Q3 Earnings Miss ↗
March 12, 2026
Via Chartmill
News headline image
Champions Oncology to Announce First Quarter Financial Results on Thursday, September 10, 2026
September 04, 2026
From Champions Oncology, Inc.
Via ACCESS Newswire
News headline image
Champions Oncology Expands Integrated Radiopharmaceutical Development Platform with In-House SPECT/CT Imaging
September 01, 2026
From Champions Oncology, Inc.
Via ACCESS Newswire
News headline image
Champions Oncology Q4 Earnings Call Highlights ↗
July 27, 2026
Via MarketBeat
Topics Earnings
News headline image
Champions Oncology Reports Record Annual Revenue of $59 Million
July 27, 2026
From Champions Oncology, Inc.
Via ACCESS Newswire
News headline image
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 27, 2026
July 20, 2026
From Champions Oncology, Inc.
Via ACCESS Newswire
News headline image
Champions Oncology to Present New Data on Predicting Response and Resistance at AACR 2026
April 09, 2026
Via ACCESS Newswire
News headline image
Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy
March 30, 2026
Via ACCESS Newswire
News headline image
Champions Oncology (CSBR) Earnings Transcript ↗
March 13, 2026
Via The Motley Fool
News headline image
Champions Oncology Reports Revenue of $16.6 Million
March 12, 2026
Via ACCESS Newswire
News headline image
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026
March 05, 2026
Via ACCESS Newswire
News headline image
Fund Discloses $25 Million Braze Stock Investment Amid 60% Share Plunge ↗
February 20, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Battery Management Dumps $9 Million Zeta Stake as Shares Slide 38% Year Over Year ↗
February 20, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Battery Takes $124 Million Bet on Kodiak AI. Here's What Investors Should Know ↗
February 20, 2026
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Sprinklr Stock Down 40% in a Year as One Fund Sells Nearly $3 Million Worth of Shares ↗
February 20, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Champions Oncology (CSBR) Earnings Call Transcript ↗
January 07, 2026
Via The Motley Fool
Topics Earnings
News headline image
Champions Oncology (CSBR) Earnings Transcript ↗
January 07, 2026
Via The Motley Fool
News headline image
Champions Oncology Inc (NASDAQ:CSBR) Beats Revenue Estimates and Returns to Profitability in Q2 ↗
December 15, 2025
Via Chartmill
News headline image
Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million
December 15, 2025
Via ACCESS Newswire
News headline image
CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million
September 15, 2025
Via ACCESS Newswire

Frequently Asked Questions

Is Champions Oncology, Inc. - Common Stock publicly traded?
Yes, Champions Oncology, Inc. - Common Stock is publicly traded.
What exchange does Champions Oncology, Inc. - Common Stock trade on?
Champions Oncology, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Champions Oncology, Inc. - Common Stock?
The ticker symbol for Champions Oncology, Inc. - Common Stock is CSBR on the Nasdaq Stock Market
What is the current price of Champions Oncology, Inc. - Common Stock?
The current price of Champions Oncology, Inc. - Common Stock is 5.150
When was Champions Oncology, Inc. - Common Stock last traded?
The last trade of Champions Oncology, Inc. - Common Stock was at 10/21/26 09:38 AM ET
What is the market capitalization of Champions Oncology, Inc. - Common Stock?
The market capitalization of Champions Oncology, Inc. - Common Stock is 69.09M
How many shares of Champions Oncology, Inc. - Common Stock are outstanding?
Champions Oncology, Inc. - Common Stock has 69M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap